Aurobindo Pharma Ltd.
| BSE: 524804 | Sector: Health care |
| NSE: AUROPHARMA | ISIN Code: INE406A01037 |
| BSE 00:00 | 25 May | 523.15 |
-15.45 (-2.87%) |
OPEN
535.00 |
HIGH
544.00 |
LOW
514.50 |
| NSE 00:00 | 25 May | 523.10 |
-15.45 (-2.87%) |
OPEN
541.10 |
HIGH
544.00 |
LOW
514.10 |
| OPEN | 535.00 |
| PREVIOUS CLOSE | 538.60 |
| VOLUME | 94149 |
| 52-Week high | 1043.00 |
| 52-Week low | 514.50 |
| P/E | 20.10 |
| Mkt Cap.(Rs cr) | 30,651 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Aurobindo Pharma Ltd. (AUROPHARMA) - Net Profit
Net Profit
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
| Aurobindo Pharma | 523.15 | -15.45 | -2.87 | 3112.91 |
| Cipla | 971.35 | 0.85 | 0.09 | 2468.28 |
| Dr Reddy's Labs | 4304.95 | -46.15 | -1.06 | 2186.40 |
| Sun Pharma.Inds. | 911.15 | 0.95 | 0.10 | 2139.70 |
| Divi's Lab. | 3518.70 | -143.35 | -3.91 | 1954.72 |
| Alkem Lab | 2967.65 | 35.25 | 1.20 | 1685.08 |
| Glenmark Pharma. | 386.75 | -7.80 | -1.98 | 1649.45 |
| Zydus Lifesci. | 366.25 | -1.90 | -0.52 | 1476.20 |
| Lupin | 590.30 | -10.85 | -1.80 | 1258.62 |
| Alembic Pharma | 741.00 | -15.35 | -2.03 | 1175.39 |
| Ipca Labs. | 938.00 | -17.60 | -1.84 | 1140.77 |
| Torrent Pharma. | 2634.55 | 42.05 | 1.62 | 1137.85 |
| Gland Pharma | 2743.50 | -128.15 | -4.46 | 997.01 |
| Laurus Labs | 553.95 | -13.20 | -2.33 | 956.11 |
| Sanofi India | 6503.50 | -84.30 | -1.28 | 944.40 |
| Abbott India | 18068.30 | -123.50 | -0.68 | 690.69 |
| Ajanta Pharma | 1701.25 | 1.95 | 0.11 | 675.64 |
| Wockhardt | 262.40 | -16.90 | -6.05 | 593.29 |
| Granules India | 254.15 | -26.60 | -9.47 | 552.78 |
| Pfizer | 4262.20 | 3.60 | 0.08 | 497.61 |
Quick Links for Aurobindo Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
